Recombinant Human P4Ha2 Protein，His

P4Ha2, a member of the prolyl 4-hydroxylase family, plays a crucial role in collagen biosynthesis by catalyzing the hydroxylation of proline residues in collagen precursors, which is essential for the stability and functionality of the collagen triple helix. The study of P4Ha2 has garnered significant attention due to its involvement in various physiological processes and its implications in pathological conditions, including fibrosis, cancer, and other connective tissue disorders. Dysregulation of P4Ha2 activity has been linked to impaired collagen formation, leading to compromised structural integrity in tissues. Moreover, research has shown that P4Ha2 can influence cellular responses to hypoxia and play a role in the modulation of tumor microenvironments, making it a potential therapeutic target. Investigating the regulatory mechanisms of P4Ha2 expression and activity, as well as its interactions with other molecular pathways, offers promising avenues for developing novel strategies for treating diseases associated with collagen accumulation and degradation. Moreover, understanding P4Ha2's role in collagen metabolism could provide insights into aging-related changes in connective tissues, thus broadening the scope of its significance in both fundamental biology and clinical applications. This growing interest is reflected in the increasing number of studies aimed at elucidating the functional dynamics of P4Ha2, paving the way for innovative approaches in regenerative medicine and targeted therapies.